Article Contents ::

Details About Generic Salt ::  Albutero

Main Medicine Class:: Bronchodilator, Sympathomimetic   

(al-BYOO-ter-ahl)
Airet
Solution for inhalation: 0.083% (as sulfate)
Proventil
Tablets: 2 mg (as sulfate), 4 mg (as sulfate)
Syrup: 2 mg (as sulfate) per 5 mL
Aerosol: Each actuation delivers 90 mcg albuterol
Solution for inhalation: 0.083% (as sulfate), 0.5% (as sulfate)
Proventil HFA
Aerosol: Each actuation delivers 90 mcg albuterol (as sulfate)
Proventil Repetabs
Tablets, extended-release: 4 mg (as sulfate)
Ventolin
Tablets: 2 mg (as sulfate), 4 mg (as sulfate)
Syrup: 2 mg (as sulfate) per 5 mL
Aerosol: Each actuation delivers 90 mcg albuterol
Solution for inhalation: 0.5% (as sulfate)
Ventolin Nebules
Solution for inhalation: 0.083% (as sulfate)
Ventolin Rotacaps
Capsules for inhalation: 200 mcg microfine (as sulate)
Volmax
Tablets, extended-release: 4 mg (as sulfate), 8 mg (as sulfate)
Alti-Salbutamol Sulfate
Asmavent
Gen-Salbutamol Sterinebs P.F.
Novo-Salmol
PMS-Salbutamol Respirator Solution
Rho-Salbutamol
Salbutamol Nebuamp
Ventodisk Disk/Diskhaler
Ventolin Injection
Ventolin Nebules P.F./Respirator Solution
Ventolin Rotocaps/Rotahaler
Ventolin Tablets
Class: Bronchodilator, Sympathomimetic

 Indications Prevention and treatment of reversible bronchospasm associated with asthma and other obstructive pulmonary diseases.

Adjunctive treatment of hyperkalemia in patients undergoing dialysis.

 Contraindications Cardiac tachyarrhythmias.

 Route/Dosage

Inhalation Aerosol

ADULTS AND CHILDREN ³ 4 yr (³ 12 yr for Proventil): 1 to 2 inhalations q 4 to 6 hr. prevention of exercise-induced bronchospasm: 2 inhalations 15 min before exercise.

Inhalation Solution

ADULTS AND CHILDREN ³ 2 yr: 2.5 mg/dose 3 to 4 times/day by nebulization. CHILDREN 2 to 12 yr (AccuNeb): 1.25 mg or 0.63 mg 3 to 4 times/day by nebulization.

Oral

ADULTS AND CHILDREN ³ 12 yr: PO 2 to 4 mg/dose 3 to 4 times/day. Do not exceed 32 mg/day. CHILDREN 6 to 12 yr: PO 2 mg/dose 3 to 4 times/day. Do not exceed 24 mg/day. CHILDREN 2 to 6 yr: PO 0.1 to 0.2 mg/kg/dose 3 times/day. Do not exceed 12 mg/day. ADULTS AND CHILDREN > 12 yr, Extended-Release (Volmax): PO 8 mg q 12 hr. 4 mg q 12 hr may be sufficient in some patients. May be cautiously increased stepwise under physician supervision to a max of 16 mg bid (max 32 mg/day). ADULTS AND CHILDREN > 12 yr, Extended-Release (Proventil Repetabs): PO 4 to 8 mg q 12 hr. May be cautiously increased stepwise to a max of 16 mg bid (max 32 mg/day). CHILDREN 6 to 12 yr, Extended-Release (Volmax): PO 4 mg q 12 hr. May be cautiously increased by steps under health care provider supervision to a max of 24 mg/day in divided doses if symptoms are not controlled. CHILDREN 6 to 12 yr, Extended-Release (Proventil Repetabs): PO 4 q 12 hr. May be cautiously increased stepwise to a max of 12 mg bid.

Syrup

ADULTS AND CHILDREN > 12 yr: 2 or 4 mg (1 to 2 tsp) 3 or 4 times/day. Doses of > 4 mg 4 times/day may be appropriate when patient fails to respond. CHILDREN 6 to 12 yr: 2 mg (1 tsp) 3 or 4 times/day. Doses of 2 mg 4 times/day may be cautiously increased. Do not exceed 24 mg/day in divided doses. CHILDREN 2 to 6 yr: Initiate at 0.1 mg/kg 3 times/day. Dose may be increased 2 mg 3 times/day. Do not exceed 2 mg 3 times/day. Dose may be increased to 0.2 mg/kg 3 times/day, but not to exceed 4 mg 3 times/day. Elderly and those sensitive to b-adrenergic stimulation: Restrict initial dose to 2 mg (1 tsp) 3 or 4 times/day. Individualize dosage thereafter.

 Interactions

Beta-Blockers: Severe bronchospasms may be produced in asthmatic patients taking albuterol. Digoxin: Albuterol may decrease serum digoxin levels. Diuretics: ECG changes and hypokalemia associated with these diuretics may worsen with albuterol coadministration.

 Lab Test Interferences None well documented.

 Adverse Reactions

CARDIOVASCULAR: Palpitations; tachycardia; elevated BP; chest tightness; angina. CNS: Tremor; dizziness; hyperactivity; nervousness; headache; insomnia; weakness; drowsiness; restlessness. EENT: Dry mouth; throat irritation. GI: Nausea; vomiting; heartburn; diarrhea. GU: Urinary retention. RESPIRATORY: Cough; bronchospasm; wheezing; dyspnea. OTHER: Flushing; sweating; anorexia; unusual sensory changes.

 Precautions

Pregnancy: Category C. Lactation: Unknown. Labor and Delivery: May inhibit uterine contractions. CHILDREN: Albuterol aerosol and inhalation powder in children < 4 yr and albuterol solution for inhalation in children < 2 yr have not been established. Cardiovascular Effects: Toxic symptoms may occur in patients with cardiovascular disorders. CNS Effects: CNS stimulation may occur; use cautiously in patients with history of seizures or hyperthyroidism. Diabetes: Dosage adjustment of insulin or oral hypoglycemic agent may be required. Excessive Use: Paradoxical bronchospasm and cardiac arrest have been associated with excessive inhalant use. Hypokalemia: Decreases in potassium levels have occurred. Tolerance: If previously effective dose fails to provide relief, therapy may need to be reassessed.

PATIENT CARE CONSIDERATIONS


 Administration/Storage

  • Do not crush or chew tablets.
  • Administer oral preparations with meals to minimize GI upset.
  • Use before other inhalation therapy and before postural drainage.
  • Allow 1 to 2 min between metered-dose inhalations and 5 min before administering other inhalant medications. Permit patient to rinse mouth after each completed inhalation dose.
  • Store at room temperature. Refrigeration of syrup improves palatability.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Check pulse, BP, respiration, and lung sounds before and after administration.
  • Review baseline and any follow-up ECG. If patient takes digoxin, check baseline and any follow-up serum digoxin levels.
  • If patient is diabetic, check baseline and follow-up blood sugar levels.
  • If bronchospasm occurs, withhold drug and report to health care provider.
  • During pregnancy, monitor fetal heart rate and report tachycardia (> 140 bpm).
OVERDOSAGE: SIGNS & SYMPTOMS
  Tremor, palpitations, tachycardia, elevated BP, seizures

 Patient/Family Education

  • Tell patient not to chew or crush capsules.
  • Teach patient correct method for using metered-dose inhaler. Have patient demonstrate proper technique, including timing between inhalations.
  • Instruct patient in home monitoring of pulse and BP.
  • Advise patient to maintain fluid intake of 2000 mL/day and to rinse mouth after each complete dose.
  • Instruct patient not to use otc inhalers without consulting health care provider.
  • Instruct patient to contact health care provider if symptoms are not relieved by normal dose.
  • Tell patient to report adverse reactions or side effects.

–>

 

Drugs Class ::

(al-BYOO-ter-ahl)
Airet
Solution for inhalation: 0.083% (as sulfate)
Proventil
Tablets: 2 mg (as sulfate), 4 mg (as sulfate)
Syrup: 2 mg (as sulfate) per 5 mL
Aerosol: Each actuation delivers 90 mcg albuterol
Solution for inhalation: 0.083% (as sulfate), 0.5% (as sulfate)
Proventil HFA
Aerosol: Each actuation delivers 90 mcg albuterol (as sulfate)
Proventil Repetabs
Tablets, extended-release: 4 mg (as sulfate)
Ventolin
Tablets: 2 mg (as sulfate), 4 mg (as sulfate)
Syrup: 2 mg (as sulfate) per 5 mL
Aerosol: Each actuation delivers 90 mcg albuterol
Solution for inhalation: 0.5% (as sulfate)
Ventolin Nebules
Solution for inhalation: 0.083% (as sulfate)
Ventolin Rotacaps
Capsules for inhalation: 200 mcg microfine (as sulate)
Volmax
Tablets, extended-release: 4 mg (as sulfate), 8 mg (as sulfate)
Alti-Salbutamol Sulfate
Asmavent
Gen-Salbutamol Sterinebs P.F.
Novo-Salmol
PMS-Salbutamol Respirator Solution
Rho-Salbutamol
Salbutamol Nebuamp
Ventodisk Disk/Diskhaler
Ventolin Injection
Ventolin Nebules P.F./Respirator Solution
Ventolin Rotocaps/Rotahaler
Ventolin Tablets
Class: Bronchodilator, Sympathomimetic

Indications for Drugs ::

 Indications Prevention and treatment of reversible bronchospasm associated with asthma and other obstructive pulmonary diseases.

Adjunctive treatment of hyperkalemia in patients undergoing dialysis.

Drug Dose ::

 Route/Dosage

Inhalation Aerosol

ADULTS AND CHILDREN ³ 4 yr (³ 12 yr for Proventil): 1 to 2 inhalations q 4 to 6 hr. prevention of exercise-induced bronchospasm: 2 inhalations 15 min before exercise.

Inhalation Solution

ADULTS AND CHILDREN ³ 2 yr: 2.5 mg/dose 3 to 4 times/day by nebulization. CHILDREN 2 to 12 yr (AccuNeb): 1.25 mg or 0.63 mg 3 to 4 times/day by nebulization.

Oral

ADULTS AND CHILDREN ³ 12 yr: PO 2 to 4 mg/dose 3 to 4 times/day. Do not exceed 32 mg/day. CHILDREN 6 to 12 yr: PO 2 mg/dose 3 to 4 times/day. Do not exceed 24 mg/day. CHILDREN 2 to 6 yr: PO 0.1 to 0.2 mg/kg/dose 3 times/day. Do not exceed 12 mg/day. ADULTS AND CHILDREN > 12 yr, Extended-Release (Volmax): PO 8 mg q 12 hr. 4 mg q 12 hr may be sufficient in some patients. May be cautiously increased stepwise under physician supervision to a max of 16 mg bid (max 32 mg/day). ADULTS AND CHILDREN > 12 yr, Extended-Release (Proventil Repetabs): PO 4 to 8 mg q 12 hr. May be cautiously increased stepwise to a max of 16 mg bid (max 32 mg/day). CHILDREN 6 to 12 yr, Extended-Release (Volmax): PO 4 mg q 12 hr. May be cautiously increased by steps under health care provider supervision to a max of 24 mg/day in divided doses if symptoms are not controlled. CHILDREN 6 to 12 yr, Extended-Release (Proventil Repetabs): PO 4 q 12 hr. May be cautiously increased stepwise to a max of 12 mg bid.

Syrup

ADULTS AND CHILDREN > 12 yr: 2 or 4 mg (1 to 2 tsp) 3 or 4 times/day. Doses of > 4 mg 4 times/day may be appropriate when patient fails to respond. CHILDREN 6 to 12 yr: 2 mg (1 tsp) 3 or 4 times/day. Doses of 2 mg 4 times/day may be cautiously increased. Do not exceed 24 mg/day in divided doses. CHILDREN 2 to 6 yr: Initiate at 0.1 mg/kg 3 times/day. Dose may be increased 2 mg 3 times/day. Do not exceed 2 mg 3 times/day. Dose may be increased to 0.2 mg/kg 3 times/day, but not to exceed 4 mg 3 times/day. Elderly and those sensitive to b-adrenergic stimulation: Restrict initial dose to 2 mg (1 tsp) 3 or 4 times/day. Individualize dosage thereafter.

Contraindication ::

 Contraindications Cardiac tachyarrhythmias.

Drug Precautions ::

 Precautions

Pregnancy: Category C. Lactation: Unknown. Labor and Delivery: May inhibit uterine contractions. CHILDREN: Albuterol aerosol and inhalation powder in children < 4 yr and albuterol solution for inhalation in children < 2 yr have not been established. Cardiovascular Effects: Toxic symptoms may occur in patients with cardiovascular disorders. CNS Effects: CNS stimulation may occur; use cautiously in patients with history of seizures or hyperthyroidism. Diabetes: Dosage adjustment of insulin or oral hypoglycemic agent may be required. Excessive Use: Paradoxical bronchospasm and cardiac arrest have been associated with excessive inhalant use. Hypokalemia: Decreases in potassium levels have occurred. Tolerance: If previously effective dose fails to provide relief, therapy may need to be reassessed.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

CARDIOVASCULAR: Palpitations; tachycardia; elevated BP; chest tightness; angina. CNS: Tremor; dizziness; hyperactivity; nervousness; headache; insomnia; weakness; drowsiness; restlessness. EENT: Dry mouth; throat irritation. GI: Nausea; vomiting; heartburn; diarrhea. GU: Urinary retention. RESPIRATORY: Cough; bronchospasm; wheezing; dyspnea. OTHER: Flushing; sweating; anorexia; unusual sensory changes.

Drug Mode of Action ::  

(al-BYOO-ter-ahl)
Airet
Solution for inhalation: 0.083% (as sulfate)
Proventil
Tablets: 2 mg (as sulfate), 4 mg (as sulfate)
Syrup: 2 mg (as sulfate) per 5 mL
Aerosol: Each actuation delivers 90 mcg albuterol
Solution for inhalation: 0.083% (as sulfate), 0.5% (as sulfate)
Proventil HFA
Aerosol: Each actuation delivers 90 mcg albuterol (as sulfate)
Proventil Repetabs
Tablets, extended-release: 4 mg (as sulfate)
Ventolin
Tablets: 2 mg (as sulfate), 4 mg (as sulfate)
Syrup: 2 mg (as sulfate) per 5 mL
Aerosol: Each actuation delivers 90 mcg albuterol
Solution for inhalation: 0.5% (as sulfate)
Ventolin Nebules
Solution for inhalation: 0.083% (as sulfate)
Ventolin Rotacaps
Capsules for inhalation: 200 mcg microfine (as sulate)
Volmax
Tablets, extended-release: 4 mg (as sulfate), 8 mg (as sulfate)
Alti-Salbutamol Sulfate
Asmavent
Gen-Salbutamol Sterinebs P.F.
Novo-Salmol
PMS-Salbutamol Respirator Solution
Rho-Salbutamol
Salbutamol Nebuamp
Ventodisk Disk/Diskhaler
Ventolin Injection
Ventolin Nebules P.F./Respirator Solution
Ventolin Rotocaps/Rotahaler
Ventolin Tablets
Class: Bronchodilator, Sympathomimetic

Drug Interactions ::

 Interactions

Beta-Blockers: Severe bronchospasms may be produced in asthmatic patients taking albuterol. Digoxin: Albuterol may decrease serum digoxin levels. Diuretics: ECG changes and hypokalemia associated with these diuretics may worsen with albuterol coadministration.

Drug Assesment ::

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Check pulse, BP, respiration, and lung sounds before and after administration.
  • Review baseline and any follow-up ECG. If patient takes digoxin, check baseline and any follow-up serum digoxin levels.
  • If patient is diabetic, check baseline and follow-up blood sugar levels.
  • If bronchospasm occurs, withhold drug and report to health care provider.
  • During pregnancy, monitor fetal heart rate and report tachycardia (> 140 bpm).
OVERDOSAGE: SIGNS & SYMPTOMS
  Tremor, palpitations, tachycardia, elevated BP, seizures

Drug Storage/Management ::

 Administration/Storage

  • Do not crush or chew tablets.
  • Administer oral preparations with meals to minimize GI upset.
  • Use before other inhalation therapy and before postural drainage.
  • Allow 1 to 2 min between metered-dose inhalations and 5 min before administering other inhalant medications. Permit patient to rinse mouth after each completed inhalation dose.
  • Store at room temperature. Refrigeration of syrup improves palatability.

Drug Notes ::

 Patient/Family Education

  • Tell patient not to chew or crush capsules.
  • Teach patient correct method for using metered-dose inhaler. Have patient demonstrate proper technique, including timing between inhalations.
  • Instruct patient in home monitoring of pulse and BP.
  • Advise patient to maintain fluid intake of 2000 mL/day and to rinse mouth after each complete dose.
  • Instruct patient not to use otc inhalers without consulting health care provider.
  • Instruct patient to contact health care provider if symptoms are not relieved by normal dose.
  • Tell patient to report adverse reactions or side effects.

–>

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.